[68Ga]-DOTATATE PET/MRI as an adjunct imaging modality for radiation treatment planning of meningiomas.
Sean S MahaseDiana A Roth O'BrienDiana NoMichelle RoytmanMyrto E SkafidaEaton LinNicolas A KarakatsanisJoseph R OsborneAndrew BrandmaierSusan C PannulloRohan RamakrishnaPhilip E StiegJonathan P S KniselyJana IvanidzePublished in: Neuro-oncology advances (2021)
Incorporating DOTATATE-PET/MRI for postoperative target delineation in patients with intermediate-risk intracranial meningiomas results in PTV reduction and decreased OAR dose. Our findings warrant larger studies evaluating DOTATATE-PET/MRI in the radiotherapeutic planning of postoperative meningiomas.